Dr Anastasia Chalkidou

Who Dr Anastasia Chalkidou is

Dr Anastasia Chalkidou is the Programme Director for HealthTech at NICE, where she leads the guidance delivery programme for health technologies including medical devices, diagnostics, and digital health tools. Before joining NICE, she was Associate Director for the King's Technology Evaluation Centre (KiTEC) and a Senior Research Fellow in Health Technology Assessment at King's College London, with a focus on complex interventions, medical devices, and digital health technologies. She has led numerous national and hospital-based HTA projects and has provided consultancy to MedTech companies on evidence generation strategies. She is a co-investigator on ASSESS-DHT, a European initiative for HTA of digital health technologies. Her career began in clinical oncology; she holds a medical degree (2004), an MSc in Nanoscience and Nanotechnology, a PhD in the validation of PET biomarkers in oncology, and an MA in Higher Education Practice. She has been publicly quoted on NICE guidance recommending digital health tools, including on reducing health inequalities through digital technology access.

References for this biography

1. 1.Dr Anastasia Chalkidou – NICE Conference 2026 — Current role as HealthTech Programme Director at NICE, prior career at KiTEC/King's College London, academic qualifications, and NHS England CTE scheme evaluations
2. 2.techUK Health and Care Summit 2025 – Speakers — Full job title 'Programme Director, Guidance Delivery – HealthTech' at NICE, ASSESS-DHT co-investigator role, career background in clinical oncology
3. 3.NICE recommends digital platforms to help people manage asthma – Digital Health — Press quotation in UK health media as NICE HealthTech programme director on digital health guidance and health inequalities
4. 4.Digital platforms recommended to help people manage their asthma – NICE — Official NICE source confirming Dr Chalkidou's role and public commentary on digital health guidance
5. 5.Dr Anastasia Chalkidou – Google Scholar — Academic citation record (2,200+), verified nice.org.uk institutional email, research areas including HTA, medical devices, and medical imaging
6. 6.Dr Anastasia Chalkidou – Hospital Association of South Africa Conference — Academic qualifications (MSc, PhD, MA), ASSESS-DHT co-investigator role, career summary
7. 7.Anastasia Chalkidou – LinkedIn — HSJ Digital Health Leader of the Year Highly Commended award; current NICE affiliation

Notable achievements

• Led the independent evaluation of two national Commissioning through Evaluation schemes for NHS England Source ↗
• Won Highly Commended Digital Health Leader of the Year at the HSJ Digital Awards Source ↗
• Co-investigator on ASSESS-DHT, a European initiative for HTA of Digital Health Technologies Source ↗
• Cited over 2,200 times in academic literature on health technology assessment, medical devices, and medical imaging Source ↗

What Dr Anastasia Chalkidou has said

• “A diagnosis of endometriosis can for some women take the best part of a decade, with the UK average standing at 9 years and 4 months, and rising to 11 years for those from ethnically diverse community. That delay means living with chronic pelvic pain that affects daily life, relationships and work. These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier allowing earlier and better treatment.”

  Healthtech Programme Director at NICE · Women's health & gynaecology · 30 Sept 2026 · NICE backs new non-invasive tests to speed up endometriosis diagnosis ↗

• “A diagnosis of endometriosis can for some women take the best part of a decade, with the UK average standing at nine years and four months, and rising to 11 years for those from ethnically diverse communities. That delay means living with chronic pelvic pain that affects daily life, relationships and work. These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier, allowing earlier and better treatment.”

  healthtech programme director at NICE · Women's health & gynaecology · 30 Sept 2026 · New endometriosis tests set to dramatically speed up diagnosis ↗

• “A diagnosis of endometriosis can for some women take the best part of a decade, with the UK average standing at 9 years and 4 months, and rising to 11 years for those from ethnically diverse communities. That delay means living with chronic pelvic pain that affects daily life, relationships and work. These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier, allowing earlier and better treatment.”

  healthtech programme director at NICE · Women's health & gynaecology · 30 Sept 2026 · NICE recommends two technologies for endometriosis diagnosis ↗

• “A diagnosis of endometriosis can for some women take the best part of a decade, with the UK average standing at 9 years and 4 months, and rising to 11 years for those from ethnically diverse communities. That delay means living with chronic pelvic pain that affects daily life, relationships and work. These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier allowing earlier and better treatment.”

  Healthtech programme director at NICE · Women's health & gynaecology · 30 Sept 2026 · NICE recommends non-invasive tests that could speed up endometriosis diagnoses ↗

• “A diagnosis of endometriosis can for some women take the best part of a decade, with the UK average standing at 9 years and 4 months, and rising to 11 years for those from ethnically diverse communities. That delay means living with chronic pelvic pain that affects daily life, relationships and work. These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier allowing earlier and better treatment.”

  Healthtech programme director at NICE · Women's health & gynaecology · 30 Sept 2026 · New technologies could help cut years-long wait for endometriosis diagnosis ↗

• “A diagnosis of endometriosis can, for some women, take the best part of a decade, with the UK average standing at nine years and four months, and rising to 11 years for those from ethnically diverse communities. That delay means living with chronic pelvic pain that affects daily life, relationships and work.”

  healthtech programme director at NICE · Women's health & gynaecology · 30 Sept 2026 · Speeding up gynaecological diagnoses ↗

• “The research shows real benefits for patients, with reduced binge eating episodes and less severe symptoms. What's particularly encouraging is that this digital therapy can work alongside existing NHS care, providing extra support without needing more healthcare staff.”

  HealthTech programme director at NICE · Children's health · 10 Sept 2026 · GPs told not to restrict eating disorder referral based on BMI in new guidance ↗

• “Our independent committee has rigorously assessed the evidence for these digital technologies and concluded they show real promise in helping people better manage their asthma. By recommending earlier access to these innovations while further evidence is gathered, we're driving transformational care into the hands of patients and healthcare professionals faster – while ensuring value for the NHS.”

  NICE HealthTech programme director · Respiratory (asthma/COPD) · 10 Sept 2026 · GPs should use AI to interpret spirometry tests, NICE proposes ↗

• “These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier allowing earlier and better treatment.”

  healthtech programme director at NICE · Maternity & neonatal · 10 Sept 2026 · NICE recommends new tests for endometriosis in primary care ↗

• “A diagnosis of endometriosis can for some women take the best part of a decade, with the UK average standing at nine years and four months, and rising to 11 years for those from ethnically diverse communities.”

  Nice's healthtech programme director · Hospital discharge / bed-blocking · 27 Aug 2026 · Rapid endometriosis tests to be made available on NHS in England and Wales ↗

• “Every donated lung is a precious gift, and right now too many of them never reach a patient who needs them. This technology has the potential to change that, giving transplant teams the time and information they need to make the most of organs that would otherwise go unused.”

  healthtech programme director at Nice · Hospital discharge / bed-blocking · 27 Aug 2026 · Machine that keeps lungs alive outside body could increase NHS transplants ↗

Where Dr Anastasia Chalkidou has been quoted

1. NICE recommends digital platforms to help manage asthmadigitalhealth.net · 30 Sept 2026
2. NICE backs new non-invasive tests to speed up endometriosis diagnosisnationalhealthexecutive.com · 30 Sept 2026
3. New endometriosis tests set to dramatically speed up diagnosisnews.sky.com · 30 Sept 2026
4. NICE recommends two technologies for endometriosis diagnosisdigitalhealth.net · 30 Sept 2026
5. NICE recommends non-invasive tests that could speed up endometriosis diagnosespharmaceutical-journal.com · 30 Sept 2026
6. New technologies could help cut years-long wait for endometriosis diagnosismft.nhs.uk · 30 Sept 2026
7. Speeding up gynaecological diagnoseshealthcaretoday.com · 30 Sept 2026
8. GPs told not to restrict eating disorder referral based on BMI in new guidancepulsetoday.co.uk · 10 Sept 2026
9. GPs should use AI to interpret spirometry tests, NICE proposespulsetoday.co.uk · 10 Sept 2026
10. NICE recommends new tests for endometriosis in primary carepulsetoday.co.uk · 10 Sept 2026
11. Rapid endometriosis tests to be made available on NHS in England and Walestheguardian.com · 27 Aug 2026
12. Machine that keeps lungs alive outside body could increase NHS transplantstheguardian.com · 27 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

• Cervical Cancer Screening: Analyzing Recent Guideline Changes Against Current Trends of Human Papillomavirus (HPV) Risk FactorsCureus
• Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthroughSouth China Morning Post
• Your strength workout can double as cardio – experts explain how to get both benefitsWomen's Health

Contact & links

• LinkedInhttps://www.linkedin.com/in/anastasia-chalkidou-98130740/
• Staff pagehttps://niceconference.co.uk/dr-anastasia-chalkidou/
• ORCIDhttps://scholar.google.com/citations?user=OA2tWYYAAAAJ&hl=en

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.